Atlas Trials

Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia

Clinical trial NCT00270478 · COMPLETED

Trial details

NCT number
NCT00270478
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sickle Cell DiseaseChronic Kidney DiseasePulmonary Hypertension
Start date
2005-12-21
Primary completion
2009-08-31
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.